TACLIBRETY Trademark

Trademark Overview

On Friday, December 29, 2017, a trademark application was filed for TACLIBRETY with the United States Patent and Trademark Office. The USPTO has given the TACLIBRETY trademark a serial number of 87738396. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 16, 2021. This trademark is owned by Dyax Corp.. The TACLIBRETY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hereditary angioedema
taclibrety

General Information

Serial Number87738396
Word MarkTACLIBRETY
Filing DateFriday, December 29, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 16, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 15, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hereditary angioedema

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 16, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDyax Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803
Party NameDyax Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803

Trademark Events

Event DateEvent Description
Monday, August 16, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 16, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 8, 2021SOU EXTENSION 5 GRANTED
Monday, December 21, 2020SOU EXTENSION 5 FILED
Monday, January 11, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 21, 2020TEAS EXTENSION RECEIVED
Monday, July 27, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 27, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 23, 2020SOU EXTENSION 4 GRANTED
Tuesday, June 23, 2020SOU EXTENSION 4 FILED
Tuesday, June 23, 2020TEAS EXTENSION RECEIVED
Wednesday, January 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 6, 2020SOU EXTENSION 3 GRANTED
Monday, January 6, 2020SOU EXTENSION 3 FILED
Monday, January 6, 2020TEAS EXTENSION RECEIVED
Friday, July 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2019SOU EXTENSION 2 GRANTED
Wednesday, July 10, 2019SOU EXTENSION 2 FILED
Wednesday, July 10, 2019TEAS EXTENSION RECEIVED
Wednesday, January 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 7, 2019SOU EXTENSION 1 GRANTED
Monday, January 7, 2019SOU EXTENSION 1 FILED
Monday, January 7, 2019TEAS EXTENSION RECEIVED
Tuesday, July 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 15, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 15, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 10, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 10, 2018ASSIGNED TO EXAMINER
Tuesday, January 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 2, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

taclibrety angioedema hereditary treatment preparations pharmaceutical